Neumora Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NMRA and other ETFs, options, and stocks.About NMRA
Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience.
CEOPaul L. Berns
CEOPaul L. Berns
Employees110
Employees110
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2019
Founded2019
Employees110
Employees110
NMRA Key Statistics
Market cap166.62M
Market cap166.62M
Price-Earnings ratio-0.63
Price-Earnings ratio-0.63
Dividend yield—
Dividend yield—
Average volume747.72K
Average volume747.72K
High today$1.09
High today$1.09
Low today$0.8125
Low today$0.8125
Open price$0.84
Open price$0.84
Volume1.84M
Volume1.84M
52 Week high$17.19
52 Week high$17.19
52 Week low$0.611
52 Week low$0.611
Analyst ratings
63%
of 8 ratingsBuy
37.5%
Hold
62.5%
Sell
0%
People also own
Based on the portfolios of people who own NMRA. This list is generated using Robinhood data, and it’s not a recommendation.